Corpus ID: 39694092

In vitro susceptibility of 115 isolates of Candida to amphotericin B, fluconazole and itraconazole.

@article{Malli1996InVS,
  title={In vitro susceptibility of 115 isolates of Candida to amphotericin B, fluconazole and itraconazole.},
  author={Mich{\`e}le Malli{\'e} and Jean M. Bastide},
  journal={Drugs under experimental and clinical research},
  year={1996},
  volume={22 6},
  pages={
          301-7
        }
}
Opportunistic fungal infections are an increasingly important cause of morbidity and mortality particularly due to Candida species (1). There is also an increase of candidosis especially ascribed to acquired or induced immunodeficiency syndromes or in the event of long-term antibiotic, immuno-suppressor or cytotoxic therapies. Consequently there has been an increase in the use of systemic antifungal agents responsible for the emergence of new opportunistic fungi (2) and resistant species (3, 4… Expand
5 Citations
Candida Glabrata Arthritis: Case Report and Review of the Literature of Candida Arthritis
TLDR
Chronic corticosteroid and repeated antibiotic therapy for infectious exacerbations of chronic obstructive pulmonary disease and alcohol abuse are the presumed risk factors in this otherwise immunocompetent patient. Expand
The antifungal activity of sulfonylamido derivatives of 2-aminophenoxathiin and related compounds
Abstract Aryl/alkyl-sulfonylamido, arylsulfenylamido, arylcarboxamido and ureido/thioureido derivatives of 2-aminophenoxathiin were prepared by reaction of the title compound with sulfonyl/sulfenylExpand
The antifungal activity of 2,2'-diamino-4,4'-dithiazole derivatives is due to the possible inhibition of lanosterol-14-alpha-demethylase.
TLDR
Several of the newly synthesized compounds act as effective antifungal agents against Aspergillus and Candida spp. Expand
One stop mycology
TLDR
This listing covers the period May 1, 1997 through to June 30, 1997, which roughly corresponds with the British Mycological Society's Special Interest Committees. Expand